Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Qian Yuan Baixing, Inc. (QYBX)

Compare
0.0073
0.0000
(0.00%)
At close: April 18 at 4:00:00 PM EDT
Loading Chart for QYBX
  • Previous Close 0.0000
  • Open 0.0088
  • Bid 0.0077 x --
  • Ask 0.0100 x --
  • Day's Range 0.0088 - 0.0088
  • 52 Week Range 0.0006 - 0.0290
  • Volume 10,000
  • Avg. Volume 8,679
  • Market Cap (intraday) 668,985
  • Beta (5Y Monthly) -0.30
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Qian Yuan Baixing, Inc. focuses on the medical equipment diagnostic and biotech business. The company was formerly known as MDCorp. and changed its name to Qian Yuan Baixing, Inc. in May 2018. Qian Yuan Baixing, Inc. was founded in 2005 and is based in Seattle, Washington.

15

Full Time Employees

December 31

Fiscal Year Ends

Recent News: QYBX

View More

Performance Overview: QYBX

Trailing total returns as of 4/18/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

QYBX
48.77%
S&P 500 (^GSPC)
10.18%

1-Year Return

QYBX
14.12%
S&P 500 (^GSPC)
5.42%

3-Year Return

QYBX
22.75%
S&P 500 (^GSPC)
20.29%

5-Year Return

QYBX
40.38%
S&P 500 (^GSPC)
83.77%

Compare To: QYBX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: QYBX

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    668.98k

  • Enterprise Value

    668.98k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.49%

  • Return on Assets (ttm)

    -7.67%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    12.89M

  • Net Income Avi to Common (ttm)

    -578.72k

  • Diluted EPS (ttm)

    -0.1300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.22k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -153.81k

Research Analysis: QYBX

View More

Company Insights: QYBX

Research Reports: QYBX

View More

People Also Watch